BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2009
View Archived Issues
Capsaicin does not impair neurologic function in postherpetic neuralgia patients
Read More
Meta-analysis data suggest possible effectiveness of levetiracetam in status epilepticus
Read More
Abbott describes novel cannabinoid CB2 receptor ligands as analgesics
Read More
Analyses point to efficacy of telmisartan/amlodipine combination in hypertension
Read More
Better blood pressure profile seen with naproxcinod than with naproxen in osteoarthritis patients
Read More
Analgesic efficacy seen with tanezumab in chronic low back pain patients
Read More
Intraocular polymer implant may improve visual acuity in AMD; preliminary phase II data presented
Read More
Vertex presents new voltage-gated sodium channel inhibitors with analgesic activity
Read More
Vernalis and Servier sign new three-year joint oncology collaboration
Read More
HGS and Novozymes amend license agreement for albumin fusion technology
Read More
Sirius and Vanderbilt University sign collaborative agreement for VALID study
Read More
Axelar reports preliminary results from phase I/II clinical trial of AXL-1717
Read More
Burzynski Research reports positive results from phase II trial of ANP therapy in OPG
Read More
Nycomed submits MAA to EMEA for PDE4 enzyme inhibitor Daxas in COPD
Read More
Pharmacopeia patent discloses Janus kinase 3 inhibitors as immmunosupressants
Read More
Novel histamine H1 receptor antagonists described by GSK as antiinflammatory agents
Read More
Gilead Sciences offers Q1 pipeline update
Read More
Actelion receives DSMB recommendation to continue with BUILD-3 study in IPF
Read More
AdventRx reports results from ANX-514 bioequivalence study
Read More
The FDA approves Cetraxal for external otitis
Read More
FDA accepts Acorda's NDA for fampridine for improving walking ability in people with MS
Read More
Isotechnika enters into strategic collaboration and financing agreement with Paladin
Read More
Maxygen and Cangene sign licensing agreement for MAXY-G34 in ARS
Read More
Exelixis and Boehringer to develop S1P1 agonists for autoimmune diseases
Read More